Speaker's profile
Yingzhong Li
SunVax TherapeuticsBIOGRAPHY
Yingzhong Li is the President of SunVax mRNA Therapeutics Inc. He holds 6 PCT patents at MIT and 3 PCT patents at SunVax in cancer immunology and mRNA techniques.
Before joining SunVax on October 30, 2021, Dr. Li gained extensive training and experience at MIT in Immunology, Synthetic Biology, Cancer Biology, and Cancer Immunotherapy.
become a speaker & join the conversation
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.